Follow the latest coverage, related explainers and connected technology stories.
Beta Bionics has received U.S. Food and Drug Administration clearance for the Mint wearable insulin pump, which is worn for three days and holds 200 units of insulin. The company plans to launch it in the United States during the first quarter of 2027 through pharmacy channels, opening direct competition with Insulet.
Senseonics has completed the transfer of marketing and sales operations for the Eversense 365 continuous glucose monitor from Ascensia Diabetes Care to its internal teams in the United States and Europe, coinciding with record revenue of $14.5 million in the second quarter. The company is developing a fully implantable version of the sensor capable of communicating directly with a phone for one year.